Sign Up to like & get
recommendations!
0
Published in 2019 at "BMC Pharmacology & Toxicology"
DOI: 10.1186/s40360-019-0376-9
Abstract: Background/objectiveFKB327 is a biosimilar of the adalimumab reference product (RP). The primary objective was to assess the relative bioavailability of FKB327 after a single subcutaneous (SC) dose via prefilled syringe (PFS), auto-injector (AI), or vial…
read more here.
Keywords:
assess relative;
relative bioavailability;
fkb327;
syringe ... See more keywords